ArticleMolecular oncology2017

MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.

Xuan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.